title: Effects of ageing and exogenous melatonin on pituitary responsiveness to GnRH in ewes during anestrus and the reproductive season.
abstract: The study examined the effect of melatonin implants on in vivo pituitary responsiveness to GnRH in control, fully productive (5.7+/-0.4 years old, n=17) and aged (10.7+/-0.3 years old, n=14) ovariectomized, estradiol-treated Rasa Aragonesa ewes. On 27 February, eight ewes in each age group received a single implant containing 18 mg melatonin. On 10 April, blood samples to be assayed for LH were collected at 10-min intervals over 4h (starting at 09:00 and 22:00 h). After samples 6 and 18 were collected, ewes received a single i.v. injection of GnRH (20 ng/kg liveweight). The pituitary response to GnRH was assessed using the difference between plasma LH concentrations before and after (highest value) each injection (DLH1, DLH2)), and the area under the LH response curve for 1h after each GnRH injection (AUC1, AUC2). On 23 September, the previously implanted ewes received a new melatonin implant and, on 17 November, all of the ewes were subjected to the same diurnal and nocturnal sampling protocols, again. Generally, non-implanted aged ewes exhibited a lower pituitary response to GnRH than did non-implanted control ewes, particularly in November and after the first injection (P<0.05 for DLH1 and AUC1 in both the diurnal and nocturnal tests). The response was significantly affected by the interaction of age and melatonin treatment, particularly in the diurnal tests (P<0.1 for DLH1 and AUC1, and P<0.05 for AUC2 in April; P<0.05 for DLH1, AUC1 and AUC2 in November), which indicated that exogenous melatonin increased LH levels after GnRH injections in aged ewes compared to non-implanted ewes, this effect being the opposite in control females. Thus, melatonin can restore in ewes the functionality of the neuroendocrine system, after it has been reduced by senescence.
authors.affiliation: Department of Animal Production and Food Science, University of Zaragoza, 177 Miguel Servet, 50013 Zaragoza, Spain. forcada@unizar.es
authors.forename: F
authors.initials: F
authors.lastname: Forcada
authors.forename: J A
authors.initials: JA
authors.lastname: Abecia
authors.forename: A
authors.initials: A
authors.lastname: Casao
authors.forename: J A
authors.initials: JA
authors.lastname: Cebrián-Pérez
authors.forename: T
authors.initials: T
authors.lastname: Muiño-Blanco
authors.forename: I
authors.initials: I
authors.lastname: Palacín
mesh_terms: D000375:Aging / Q000502:physiology*; D000780:Anestrus / Q000502:physiology*; D000818:Animals; D000975:Antioxidants / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D007986:Luteinizing Hormone / Q000097:blood; D008550:Melatonin / Q000008:administration & dosage / Q000494:pharmacology*; D010902:Pituitary Gland / Q000187:drug effects*; D012098:Reproduction / Q000502:physiology*; D012621:Seasons; D012756:Sheep / Q000502:physiology*; D013997:Time Factors
chemical_list: D000975:Antioxidants; D007986:Luteinizing Hormone; D008550:Melatonin